Do analysts recommend YI or AHCO?

AdaptHealth has a consensus target price of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than 111. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 111 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67

Is YI or AHCO more profitable?

111 has a net margin of -0.76% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat 111's return on equity. Company Net Margins Return on Equity Return on Assets 111 -0.76% N/A -3.80% AdaptHealth -7.07% 3.36% 1.16%

Do analysts prefer COSM or AHCO?

AdaptHealth has a consensus price target of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts clearly believe AdaptHealth is more favorable than Cosmos Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67

Does the media refer more to COSM or AHCO?

In the previous week, Cosmos Health had 11 more articles in the media than AdaptHealth. MarketBeat recorded 14 mentions for Cosmos Health and 3 mentions for AdaptHealth. Cosmos Health's average media sentiment score of 0.18 beat AdaptHealth's score of 0.02 indicating that Cosmos Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cosmos Health 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral AdaptHealth 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer WGRX or AHCO?

AdaptHealth has a consensus target price of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts plainly believe AdaptHealth is more favorable than Wellgistics Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67

Do analysts prefer HKPD or AHCO?

AdaptHealth has a consensus price target of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67

Which has stronger earnings and valuation, HKPD or AHCO?

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than AdaptHealth. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.33 -$1.14M N/A N/A AdaptHealth $3.24B 0.24 -$70.79M -$1.71 N/A

Do analysts prefer AHCO or RDGT?

AdaptHealth presently has a consensus price target of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher probable upside, equities analysts plainly believe AdaptHealth is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, AHCO or RDGT?

Ridgetech has lower revenue, but higher earnings than AdaptHealth. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AdaptHealth $3.24B 0.24 -$70.79M -$1.71 N/A Ridgetech $132.16M 0.02 -$1.25M N/A N/A

AdaptHealth (AHCO) Competitors

$5.63 +0.24 (+4.45%)

As of 08/21/2026 04:00 PM Eastern

Compare

AHCO vs. YI, COSM, WGRX, HKPD, and RDGT

Should you buy AdaptHealth stock or one of its competitors? AdaptHealth's main competitors and comparable companies include 111 (YI), Cosmos Health (COSM), Wellgistics Health (WGRX), Hong Kong Pharma Digital Technology (HKPD), and Ridgetech (RDGT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does AdaptHealth compare to 111?

111 (NASDAQ:YI) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

AdaptHealth has a consensus target price of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than 111.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
111	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

111 has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than 111, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
111	$1.80B	0.02	-$9.65M	-$1.40	N/A
AdaptHealth	$3.24B	0.24	-$70.79M	-$1.71	N/A

In the previous week, AdaptHealth had 3 more articles in the media than 111. MarketBeat recorded 3 mentions for AdaptHealth and 0 mentions for 111. AdaptHealth's average media sentiment score of 0.02 beat 111's score of 0.00 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Overall Sentiment
111	Neutral
AdaptHealth	Neutral

21.3% of 111 shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 43.9% of 111 shares are owned by insiders. Comparatively, 2.0% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

111 has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market.

111 has a net margin of -0.76% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat 111's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
111	-0.76%	N/A	-3.80%
AdaptHealth	-7.07%	3.36%	1.16%

Summary

AdaptHealth beats 111 on 11 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to Cosmos Health?

Cosmos Health (NASDAQ:COSM) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by company insiders. Comparatively, 2.0% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

AdaptHealth has a net margin of -7.07% compared to Cosmos Health's net margin of -33.08%. AdaptHealth's return on equity of 3.36% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-33.08%	-56.88%	-18.03%
AdaptHealth	-7.07%	3.36%	1.16%

AdaptHealth has a consensus price target of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts clearly believe AdaptHealth is more favorable than Cosmos Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

Cosmos Health has a beta of 4.8, indicating that its share price is 380% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market.

Cosmos Health has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.20	-$19.15M	-$0.64	N/A
AdaptHealth	$3.24B	0.24	-$70.79M	-$1.71	N/A

In the previous week, Cosmos Health had 11 more articles in the media than AdaptHealth. MarketBeat recorded 14 mentions for Cosmos Health and 3 mentions for AdaptHealth. Cosmos Health's average media sentiment score of 0.18 beat AdaptHealth's score of 0.02 indicating that Cosmos Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cosmos Health	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
AdaptHealth	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

AdaptHealth beats Cosmos Health on 9 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to Wellgistics Health?

Wellgistics Health (NASDAQ:WGRX) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

82.7% of AdaptHealth shares are owned by institutional investors. 27.0% of Wellgistics Health shares are owned by insiders. Comparatively, 2.0% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Wellgistics Health has a beta of -1.47, indicating that its share price is 247% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market.

In the previous week, AdaptHealth had 3 more articles in the media than Wellgistics Health. MarketBeat recorded 3 mentions for AdaptHealth and 0 mentions for Wellgistics Health. AdaptHealth's average media sentiment score of 0.02 beat Wellgistics Health's score of 0.00 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Overall Sentiment
Wellgistics Health	Neutral
AdaptHealth	Neutral

AdaptHealth has a consensus target price of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts plainly believe AdaptHealth is more favorable than Wellgistics Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

AdaptHealth has a net margin of -7.07% compared to Wellgistics Health's net margin of -545.69%. AdaptHealth's return on equity of 3.36% beat Wellgistics Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-545.69%	N/A	-145.69%
AdaptHealth	-7.07%	3.36%	1.16%

AdaptHealth has higher revenue and earnings than Wellgistics Health. AdaptHealth is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.37	-$101.28M	-$44.50	N/A
AdaptHealth	$3.24B	0.24	-$70.79M	-$1.71	N/A

Summary

AdaptHealth beats Wellgistics Health on 13 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to Hong Kong Pharma Digital Technology?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

AdaptHealth has a consensus price target of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

Hong Kong Pharma Digital Technology has a beta of 2.33, indicating that its stock price is 133% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market.

In the previous week, AdaptHealth had 3 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 3 mentions for AdaptHealth and 0 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 0.80 beat AdaptHealth's score of 0.02 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Positive
AdaptHealth	Neutral

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than AdaptHealth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.33	-$1.14M	N/A	N/A
AdaptHealth	$3.24B	0.24	-$70.79M	-$1.71	N/A

82.7% of AdaptHealth shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat Hong Kong Pharma Digital Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
AdaptHealth	-7.07%	3.36%	1.16%

Summary

AdaptHealth beats Hong Kong Pharma Digital Technology on 9 of the 14 factors compared between the two stocks.

How does AdaptHealth compare to Ridgetech?

AdaptHealth (NASDAQ:AHCO) and Ridgetech (NASDAQ:RDGT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Ridgetech has lower revenue, but higher earnings than AdaptHealth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.24	-$70.79M	-$1.71	N/A
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

AdaptHealth has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market. Comparatively, Ridgetech has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market.

AdaptHealth presently has a consensus price target of $10.29, suggesting a potential upside of 82.69%. Given AdaptHealth's stronger consensus rating and higher probable upside, equities analysts plainly believe AdaptHealth is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, AdaptHealth had 3 more articles in the media than Ridgetech. MarketBeat recorded 3 mentions for AdaptHealth and 0 mentions for Ridgetech. AdaptHealth's average media sentiment score of 0.02 beat Ridgetech's score of 0.00 indicating that AdaptHealth is being referred to more favorably in the media.

Company	Overall Sentiment
AdaptHealth	Neutral
Ridgetech	Neutral

82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 45.3% of Ridgetech shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by company insiders. Comparatively, 22.6% of Ridgetech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Ridgetech has a net margin of 0.00% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat Ridgetech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-7.07%	3.36%	1.16%
Ridgetech	N/A	N/A	N/A

Summary

AdaptHealth beats Ridgetech on 11 of the 14 factors compared between the two stocks.

Get AdaptHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AHCO vs. The Competition

Export

Metric	AdaptHealth	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$767.62M	$9.83B	$7.37B	$12.85B
Dividend Yield	N/A	2.55%	2.53%	11.08%
P/E Ratio	-3.29	34.38	272.60	24.25
Price / Sales	0.24	4.97	618.96	99.05
Price / Cash	1.34	125.12	78.62	53.99
Price / Book	0.55	4.05	13.05	6.20
Net Income	-$70.79M	$311.06M	$3.47B	$348.59M
7 Day Performance	-3.10%	0.83%	2.09%	0.08%
1 Month Performance	-46.23%	2.42%	6.64%	3.88%
1 Year Performance	-41.42%	15.69%	25.02%	16.98%

AdaptHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AHCO AdaptHealth	4.5662 of 5 stars	$5.63 +4.5%	$10.29 +82.7%	-41.4%	$767.62M	$3.24B	N/A	10,900	Analyst Forecast
YI 111	0.7223 of 5 stars	$3.76 +4.2%	N/A	-48.3%	$33.03M	$11.39B	N/A	1,063	Positive News
COSM Cosmos Health	1.9223 of 5 stars	$0.20 -0.5%	N/A	-73.7%	$12.31M	$65.27M	N/A	100	News Coverage Earnings Report Options Volume Analyst Revision Gap Up
WGRX Wellgistics Health	0.3402 of 5 stars	$3.46 -1.7%	N/A	-92.7%	$8.69M	$23.34M	N/A	31	Gap Down High Trading Volume
HKPD Hong Kong Pharma Digital Technology	0.7835 of 5 stars	$0.41 -2.1%	N/A	-60.7%	$4.52M	$13.43M	N/A	19	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AHCO) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AdaptHealth (AHCO) Competitors

AHCO vs. YI, COSM, WGRX, HKPD, and RDGT

How does AdaptHealth compare to 111?

Summary

How does AdaptHealth compare to Cosmos Health?

Summary

How does AdaptHealth compare to Wellgistics Health?

Summary

How does AdaptHealth compare to Hong Kong Pharma Digital Technology?

Summary

How does AdaptHealth compare to Ridgetech?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AdaptHealth (AHCO) Competitors

AHCO vs. YI, COSM, WGRX, HKPD, and RDGT

How does AdaptHealth compare to 111?

Do analysts recommend YI or AHCO?

Which has better earnings and valuation, YI or AHCO?

Does the media refer more to YI or AHCO?

Do insiders & institutionals have more ownership in YI or AHCO?

Which has more volatility and risk, YI or AHCO?

Is YI or AHCO more profitable?

Summary

How does AdaptHealth compare to Cosmos Health?

Do institutionals and insiders have more ownership in COSM or AHCO?

Is COSM or AHCO more profitable?

Do analysts prefer COSM or AHCO?

Which has more volatility & risk, COSM or AHCO?

Which has higher valuation and earnings, COSM or AHCO?

Does the media refer more to COSM or AHCO?

Summary

How does AdaptHealth compare to Wellgistics Health?

Do institutionals & insiders have more ownership in WGRX or AHCO?

Which has more risk and volatility, WGRX or AHCO?

Does the media prefer WGRX or AHCO?

Do analysts prefer WGRX or AHCO?

Is WGRX or AHCO more profitable?

Which has preferable valuation & earnings, WGRX or AHCO?

Summary

How does AdaptHealth compare to Hong Kong Pharma Digital Technology?

Do analysts prefer HKPD or AHCO?

Which has more risk & volatility, HKPD or AHCO?

Does the media prefer HKPD or AHCO?

Which has stronger earnings and valuation, HKPD or AHCO?

Do insiders & institutionals have more ownership in HKPD or AHCO?

Is HKPD or AHCO more profitable?

Summary

How does AdaptHealth compare to Ridgetech?

Which has stronger valuation & earnings, AHCO or RDGT?

Which has more risk and volatility, AHCO or RDGT?

Do analysts prefer AHCO or RDGT?

Does the media refer more to AHCO or RDGT?

Do institutionals & insiders hold more shares of AHCO or RDGT?

Is AHCO or RDGT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools